TITCK is the regulatory agency in charge of ensuring the safety of medicines, health products, cosmetics, and personal care products in Turkey. Its recently appointed president, Dr Tolga Karakan, discusses the agency’s work with the WHO, ICH and EU Commission to help Turkish patients and consumers, their experience with emergency use authorizations for COVID-19 vaccines, and the renewed support for clinical trials. In addition, he outlines the agency’s priorities including the activation of the country’s production capacity to grow export-oriented and bringing advanced technology and know-how to the healthcare system and industry.
The importance and urgency of developing a vaccine during the COVID-19 pandemic is obvious
